Application of microfluidic chip technology to study the inhibitory effect of tetramethylpyrazine on platelet aggregation, activation, and phosphatidylserine exposure mediated by pathological high shear rate
Application of microfluidic chip technology to study the inhibitory effect of tetramethylpyrazine on platelet aggregation, activation, and phosphatidylserine exposure mediated by pathological high shear rate
复制标题
应用微流控芯片技术研究四甲基吡嗪对病理性高剪切速率介导的血小板聚集、活化及磷脂酰丝氨酸暴露的抑制作用
DOI:
--
复制
发表时间:
2022
影响因子:
1.1
通讯作者:
Yuan Li
中科院分区:
文献类型:
--
作者:
Tian Zhang;Ling Liu;Xiaojing Huang;Xuemei Gao;Dan Chen;Xuanrong Huan;Cui He;Yuan Li
Objective In order to study the antithrombotic effect and mechanism of tetramethylpyrazine (TMA). Methods In this study, we developed a microfluidic chip model that can mimic normal arteries and stenotic arterial vessels, and studied the inhibitory effects of TMA on platelet aggregation, activation (P-selectin, GPIIb/IIIa, monocyte-platelet aggregates) and phosphatidyl serine (PS) exposure. In addition, we also investigated the effect of TMA on ADP and ristocetin-induced platelet aggregation by turbidimetry. Results The results showed that TMA significantly inhibited the platelet aggregation, activation and PS exposure induced by pathological high shear rate. Under static conditions, TMA can inhibit ADP and ristocetin-induced platelet aggregation. Conclusion The results indicated that TMA mainly inhibited platelet aggregation, activation and PS exposure by inhibiting the binding of von Willebrand factor (vWF) to the GPIb/IX/V complex, and partially inhibited platelet aggregation through the platelet P2Y12–ADP receptor pathway.
影响因子:
20.3
作者:
S. Hamburger;R. McEver
通讯作者:
S. Hamburger;R. McEver
影响因子:
3.4
作者:
Feghhi, Shirin;Munday, Adam D.;Sniadecki, Nathan J.
通讯作者:
Sniadecki, Nathan J.
影响因子:
6.1
作者:
Rahman,ShekhMojibur;Hlady,Vladimir
通讯作者:
Hlady,Vladimir